References
- Chan JCN, Cho NH, Tajima N, Shaw J. Diabetes in the Western Pacific Region—past, present and future. Diabetes Res Clin Pract. 2014; 103:244–55.
- Ramachandran A, Snehalatha C, Shetty AS, Nandhita A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012; 3:110–17.
- Suhadi R, Linawati Y, Wulandari ET, Virginia DM, Setiawan CH. The metabolic disorders and cardiovascular risk among lower socioeconomic subjects in Yogyakarta-Indonesia. Asian J Pharm Clin Res. 2017; 10:367–72.
- Sirdah MM, Reading NS. Genetic predisposition in type 2 diabetes: a promising approach toward a personalized management of diabetes. Clin Genet. 2020; 98:525–47.
- Leong A, Porneala B, Dupuis J, Florez JC, Meigs JB. Type 2 diabetes genetic predisposition, obesity, and all-cause mortality risk in the U.S.: a multiethnic analysis. Diabetes Care. 2016; 39:539–46.
- Xue A, Wu Y, Zhu Z, Zhang F, Kemper KE, Zheng Z, et al. Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes. Nat Commun. 2018; 9:2941. doi: 10.10138/s41467-018-04951-w
- Sim X, Ong RT-H, Suo C, Tay W-T, Liu J, Ng DP-K, et al. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia. PLoS Genet. 2011; 7:e1001363. doi: 10.1371/journal.pgen.1001363
- Meigs JB, Cupples LA, Wilson PWF. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes. 2000; 49:2201–7.
- Avery AR, Duncan GE. Heritability of type 2 diabetes in the Washington State Twin Registry. Twin Res Hum Genet. 2019; 22:95–8.
- Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009; 461(7265):747–53.
- Stančáková A, Laakso M. Genetics of type 2 diabetes. In: Stettler C, Christ E, Diem P, editors. Novelties in Diabetes. Basel: Karger; 2016, p. 203–20. (Mullis P-E, series editor. Endocr Dev., Vol. 31).
- Franks PW, Shungin D. The interplay of lifestyle and genetic susceptibility in type 2 diabetes risk. Diabetes Manag. 2011; 1:299–307.
- Wu L, Zhang L, Li B, Jiang H, Duan Y, Xie Z, et al. AMP-Activated protein kinase (AMPK) regulates energy metabolism through modulating thermogenesis in adipose tissue. Front Physiol. 2018; 9:122. doi: 10.3389/fphys.2018.00122
- Foretz M, Even PC, Viollet B. AMPK activation reduces hepatic lipid content by increasing fat oxidation in vivo. Int J Mol Sci. 2018; 19:2826. doi: 10.3390/ijms19092826
- Kjøbsted R, Hingst JR, Fentz J, Foretz M, Sans MN, Pehmøller C, et al. AMPK in skeletal muscle function and metabolism. FASEB J. 2018; 32:1741–77.
- Ruderman NB, Carling D, Prentki M, Cacicedo JM. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. 2013; 123:2764–72.
- Tain Y-L, Hsu C-N. AMP-Activated protein kinase as a reprogramming strategy for hypertension and kidney disease of developmental origin. Int J Mol Sci. 2018; 19:1744. doi: 10.3390/ijms19061744
- Viollet B, Andreelli F, Jørgensen SB, Perrin C, Flamez D, Mu J, et al. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. In: Hardie DG, Carling D, editors. AMPK 2002 – 2nd International Meeting on AMP-activated Protein Kinase. 2002 September 12–14, University of Dundee, Scotland, United Kingdom. Biochem Soc Trans. 2003; 31:216–9.
- Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. AMPK activation: a therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes. 2014; 7:241–53.
- Meng S, Cao J, He Q, Xiong L, Chang E, Rodovick S, et al. Metformin activates AMP-activated protein kinase by promoting formation of the αβγ heterotrimeric complex. J Biol Chem. 2015; 290:3793–802.
- Horikoshi M, Hara K, Ohashi J, Miyake K, Tokunaga K, Ito C, et al. A Polymorphism in the AMPKα2 subunit gene is associated with insulin resistance and type 2 diabetes in the Japanese population. Diabetes. 2006; 55: 919–23.
- Keshavarz P, Inoue H, Nakamura N, Yoshikawa T, Tanahashi T, Itakura M. Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK α2-subunit (PRKAA2) and risk of type 2 diabetes. Mol Genet Metab. 2008; 93:200–9.
- Wang M-r, Li R, Zhang S-h. Investigation of AMPKα2 subunit gene polymorphism of type 2 diabetes mellitus in Han populations in Chongqing. Med J Chin PLA. 2014; 39:731–5. doi: 10.11855/j.issn.0577-7402.2014.09.11 [in Chinese, English abstract]
- Shen J-Z, Ge W-H, Fang Y, Liu H. A novel polymorphism in protein kinase AMP-activated catalytic subunit alpha 2 (PRKAA2) is associated with type 2 diabetes in the Han Chinese population. J Diabetes. 2017; 9:606–12.
- Li Q, Li C, Li H, Zeng L, Kang Z, Mao Y, et al. Effect of AMP-activated protein kinase subunit alpha 2 (PRKAA2) genetic polymorphisms on susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a Chinese population. J Diabetes. 2018; 10:43–9.
- Gu HF. Genetic and epigenetic studies in diabetic kidney disease. Front Genet. 2019; 10:507. doi: 10.3389/fgene.2019.00507
- Jablonski KA, McAteer JB, de Bakker PIW, Franks PW, Pollin TI, Hanson RL, et al. Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes. 2010; 59:2672–81.
- Abdullah N, Attia J, Oldmeadow C, Scott RJ, Holliday EG. The architecture of risk for type 2 diabetes: understanding Asia in the context of global findings. Int J Endocrinol. 2014; 2014: 593982. doi: 10.1155/2014/593982
- Garlo KG, White WB, Bakris GL, Zannad F, Wilson CA, Kupfer S, et al. Kidney biomarkers and decline in eGFR in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2018; 13:398–405.
- Anutrakulchai S, Pongskul C, Sirivongs D, Tonsawan P, Thepsuthammarat K, Chanaboon S, et al. Factors associated with mortality and high treatment expense of adult patients hospitalized with chronic kidney disease in Thailand. Asian Biomed (Res Rev News). 2016; 10:15–24.
- Little J, Higgins JPT, Ioannidis JPA, Moher D, Gagnon F, von Elm E, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Hum Genet. 2009; 125:131–51.
- Li Q, Li C, Li H, Zeng L, Kang Z, Mao Y, et al. STK11 rs2075604 polymorphism is associated with metformin efficacy in Chinese type 2 diabetes mellitus. Int J Endocrinol. 2017; 2017:3402808. doi: 10.1155/2017/3402808
- Applied Biosystems. TaqMan SNP Genotyping Assays [Internet]. Thermo Fisher Scientific; 2020 [cited 2021 July 09]. Available from: https://www.thermofisher.com/order/genome-database/?pearUXVerSuffix=pearUX2&elcanoForm=true#!/genotyping/assays/genotyping_all/?keyword=rs9803799
- Jeon S-M. Regulation and function of AMPK in physiology and diseases. Exp Mol Med. 2016; 48:e245. doi: 10.1038/emm.2016.81
- Zhang Y, Chen J, Zeng Y, Huang D, Xu Q. Involvement of AMPK activation in the inhibition of hepatic gluconeogenesis by Ficus carica leaf extract in diabetic mice and HepG2 cells. Biomed Pharmacother. 2019; 109:188–94.
- Sun MW, Lee JY, De Bakker PIW, Burtt NP, Almgren P, Råstam L, et al. Haplotype structures and large-scale association testing of the 5′ AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 with type 2 diabetes. Diabetes. 2006; 55:849–55.
- Liu C-Y, Zhang W, Ji L-N, Wang J-G; ATTEND investigators. Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension. Diabetol Metab Syndr. 2019; 11:69. doi: 10.1186/s13098-019-0465-3
- Ha KH, Park CY, Jeong IK, Kim HJ, Kim SY, Kim WJ, et al. Clinical characteristics of people with newly diagnosed type 2 diabetes between 2015 and 2016: difference by age and body mass index. Diabetes Metab J. 2018; 42:137–46.
- Wang S, Ma W, Yuan Z, Wang S-M, Yi X, Jia H, Xue F. Association between obesity indices and type 2 diabetes mellitus among middle-aged and elderly people in Jinan, China: a cross-sectional study. BMJ Open. 2016; 6:e012742. doi: 10.1136/bmjopen-2016-012742
- Nature Education. Hardy-Weinberg equilibrium [Internet]. Scitable by Nature Education; 2014 [cited 2021 Feb 23]. Available from: https://www.nature.com/scitable/definition/hardy-weinberg-equilibrium-122/
- Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017; 12:2032–45.
- de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, et al. Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes Care. 2017; 40:1273–84.
- Rajani R, Pastor-Soler NM, Hallows KR. Role of AMP-activated protein kinase in kidney tubular transport, metabolism, and disease. Curr Opin Nephrol Hypertens. 2017; 26:375–83.
- Schneider H, Schubert KM, Blodow S, Kreutz C-P, Erdogmus S, Wiedenmann M, et al. AMPK dilates resistance arteries via activation of SERCA and BKCa channels in smooth muscle. Hypertension. 2015; 66:108–16.
- Cuschieri S. The genetic side of type 2 diabetes: a review. Diabetes Metab Syndr. 2019; 13:2503–6.
- Mambiya M, Shang M, Wang Y, Li Q, Liu S, Yang L, et al. The play of genes and non-genetic factors on type 2 diabetes. Front Public Health. 2019; 7:349. doi: 10.3389/fpubh.2019.00349
- American Diabetes Association. 1. Strategies for improving care. Diabetes Care. 2016; 39(Suppl 1):S6–12.
- Mahendradhata Y, Trisnantoro L, Listyadewi S, Soewondo P, Marthias T, et al. The Republic of Indonesia Health System Review. Asia Pacific Observatory on Health Systems and Policies. World Health Organization Regional Office for South-East Asia: New Delhi 110 002, India; 2017. (Hort K, Patcharanarumol W, series editors. Health Systems in Transition, Vol. 7(1)).